SYRE
Spyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
SYRE Filings
Filing Date
Form Description
Form Type
2026-04-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-01
Form 144 - Report of proposed sale of securities
Ownership
2026-04-01 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-27
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-27 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-05
Form EFFECT - Notice of Effectiveness
2026-03-05 ·
Form EFFECT - Notice of Effectiveness
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 144 - Report of proposed sale of securities
Ownership
2026-03-03 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-02
Form 144 - Report of proposed sale of securities
Ownership
2026-03-02 · Ownership
Form 144 - Report of proposed sale of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
